Gabinet lekarski Maciej Karcz

At Gabinet lekarski Maciej Karcz researchers focus on reducing major cardiovascular events in patients with established disease or high risk.

• Risk reduction for major adverse cardiovascular events
• Impact on LDL‑C and lipid profiles
• Evaluation of novel RNA‑based therapies

The trials aim to test new therapies that could lower heart attack, stroke, and vascular complications, improving long‑term outcomes.

Clinical work targets hyperlipidemia and related disorders, seeking better control of “bad” cholesterol.

• LDL‑C lowering efficacy
• Lipoprotein(a) reduction strategies
• Safety of emerging lipid‑targeting agents

By comparing investigational drugs with placebo, the studies assess whether these agents can more effectively manage cholesterol and reduce cardiovascular risk.

The site investigates treatment options for hypertension in patients with co‑existing cardiovascular disease.

• Blood pressure lowering effectiveness
• Impact on heart failure events
• Combination therapy safety

Research seeks to determine if newer agents can achieve better blood pressure control and lower the incidence of heart failure hospitalizations.